Diatech (US) changes name to Diatide:
This article was originally published in Clinica
Radiopharmaceuticals company Diatech (US) has changed its name to Diatide. The company develops peptides labelled with technetium-99m. Diatide expects to file its first New Drug Application with the US FDA for the rapid detection of deep vein thrombosis in early 1997. The company intends to file one NDA each year for products diagnosing tumours, infection of unknown origin, pulmonary embolism and atherosclerotic plaque.